There is conflicting real-world evidence regarding the risk of breast and bladder cancer associated with sodium glucose cotransporter 2 (SGLT2) inhibitors. We conducted a pharmacovigilance study on SG
The processed dataset and analysis scripts generated during the study on "Dipeptidyl Peptidase-4 Inhibitors and Hyperkalemia: A Disproportionality Analysis" . The data supporting the findings of this
Includes data files and supplemental information. Supplemental information includes a reproducible RMarkdown file, an Excel sheet with metadata, and complete webpage files. From the FAERS Q
ObjectiveThis study aims to identify the drugs most commonly associated with kidney stone-related adverse events using data from the FDA Adverse Event Reporting System (FAERS), providing insights for